Relmada Therapeutics

$35.23
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.72 (-2.00%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell RLMD and other stocks, options, and ETFs commission-free!

About RLMD

Relmada Therapeutics, Inc. Common Stock, also called Relmada Therapeutics, is a clinical-stage biotechnology company.

CEO
Sergio Traversa
Employees
14
Headquarters
New York, New York
Founded
2012
Market Cap
619.06M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
65.10K
High Today
$36.32
Low Today
$35.12
Open Price
$36.00
Volume
28.20K
52 Week High
$54.00
52 Week Low
$28.40

RLMD Earnings

-$1.28
-$0.85
-$0.43
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours

You May Also Like

PIAI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure